{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:57:06Z","timestamp":1793321826153,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The gut microbiota is involved in the pathogenesis of diabetic cardiomyopathy (DCM). Myricetin protects cardiac function in DCM. However, the low bioavailability of myricetin fails to explain its pharmacological mechanisms thoroughly. Research has shown that myricetin has a positive effect on the gut microbiota. We hypothesize that myricetin improves the development of DCM via regulating gut microbiota.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>DCM mice were induced with streptozotocin and fed a high-fat diet, and then treated with myricetin by gavage and high-fat diet for 16 weeks. Indexes related to gut microbiota composition, cardiac structure, cardiac function, intestinal barrier function, and inflammation were detected. Moreover, the gut contents were transplanted to DCM mice, and the effect of fecal microbiota transplantation (FMT) on DCM mice was assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Myricetin could improve cardiac function in DCM mice by decreasing cardiomyocyte hypertrophy and interstitial fibrosis. The composition of gut microbiota, especially for short-chain fatty acid-producing bacteria involving Roseburia, Faecalibaculum, and Bifidobacterium, was more abundant by myricetin treatment in DCM mice. Myricetin increased occludin expression and the number of goblet cells in DCM mice. Compared with DCM mice unfed with gut content, the cardiac function, number of goblet cells, and expression of occludin in DCM mice fed by gut contents were elevated, while cardiomyocyte hypertrophy and TLR4\/MyD88 pathway-related proteins were decreased.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Myricetin can prevent DCM development by increasing the abundance of beneficial gut microbiota and restoring the gut barrier function.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41387-024-00268-4","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:22:06Z","timestamp":1710278526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites"],"prefix":"10.1038","volume":"14","author":[{"given":"Jinxiu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-1749","authenticated-orcid":false,"given":"Xuerui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"268_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.diabres.2009.11.006","volume":"87","author":"N Unwin","year":"2010","unstructured":"Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract. 2010;87:2\u20133.","journal-title":"Diabetes Res Clin Pract"},{"key":"268_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229\u201334.","journal-title":"N Engl J Med"},{"key":"268_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/01.CIR.0000116389.61864.DE","volume":"109","author":"CD Lee","year":"2004","unstructured":"Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855\u201360.","journal-title":"Circulation"},{"key":"268_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1042\/CS20160491","volume":"131","author":"M Tate","year":"2017","unstructured":"Tate M, Grieve DJ, Ritchie RH. Are targeted therapies for diabetic cardiomyopathy on the horizon? Clin Sci (Lond). 2017;131:897\u2013915.","journal-title":"Clin Sci (Lond)"},{"key":"268_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"268_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57:660\u201371.","journal-title":"Diabetologia"},{"key":"268_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41420-020-00395-8","volume":"7","author":"S Zhu","year":"2021","unstructured":"Zhu S, Yang N, Guan Y, Wang X, Zang G, Lv X, et al. GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1\/2-c-Fos-LIF signaling. Cell Death Discov. 2021;7:3.","journal-title":"Cell Death Discov"},{"key":"268_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res. 2011;108:1122\u201332.","journal-title":"Circ Res"},{"key":"268_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2018.10.082","volume":"506","author":"L Lei","year":"2018","unstructured":"Lei L, Hu H, Lei Y, Feng J. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction. Biochem Biophys Res Commun. 2018;506:668\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"268_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.106","volume":"8","author":"M-X Zhao","year":"2017","unstructured":"Zhao M-X, Zhou B, Ling L, Xiong X-Q, Zhang F, Chen Q, et al. Salusin-\u03b2 contributes to oxidative stress and inflammation in diabetic cardiomyopathy. Cell Death Dis. 2017;8:e2690.","journal-title":"Cell Death Dis"},{"key":"268_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cmet.2012.10.007","volume":"16","author":"E Holmes","year":"2012","unstructured":"Holmes E, Li JV, Marchesi JR, Nicholson JK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 2012;16:559\u201364.","journal-title":"Cell Metab"},{"key":"268_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268\u201373.","journal-title":"Science"},{"key":"268_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","volume":"127","author":"M Witkowski","year":"2020","unstructured":"Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127:553\u201370.","journal-title":"Circ Res"},{"key":"268_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.009","volume":"74","author":"EC Rosser","year":"2016","unstructured":"Rosser EC, Mauri C. A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun. 2016;74:85\u201393.","journal-title":"J Autoimmun"},{"key":"268_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55\u201360.","journal-title":"Nature"},{"key":"268_CR16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761\u201372.","journal-title":"Diabetes"},{"key":"268_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11:255\u201365.","journal-title":"Nat Rev Cardiol"},{"key":"268_CR18","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.bbadis.2017.01.010","volume":"1863","author":"N Hu","year":"2017","unstructured":"Hu N, Zhang Y. TLR4 knockout attenuated high fat diet-induced cardiac dysfunction via NF-\u03baB\/JNK-dependent activation of autophagy. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2001\u201311.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"268_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.yjmcc.2018.04.009","volume":"119","author":"S Wang","year":"2018","unstructured":"Wang S, Ge W, Harns C, Meng X, Zhang Y, Ren J. Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy. J Mol Cell Cardiol. 2018;119:40\u201350.","journal-title":"J Mol Cell Cardiol"},{"key":"268_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2016.04.008","volume":"162","author":"G Du","year":"2016","unstructured":"Du G, Sun L, Zhao R, Du L, Song J, Zhang L, et al. Polyphenols: Potential source of drugs for the treatment of ischaemic heart disease. Pharm Ther. 2016;162:23\u201334.","journal-title":"Pharm Ther"},{"key":"268_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8370593","volume":"2017","author":"HH Liao","year":"2017","unstructured":"Liao HH, Zhu JX, Feng H, Ni J, Zhang N, Chen S, et al. Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting IkappaBalpha\/NFkappaB and enhancing Nrf2\/HO-1. Oxid Med Cell Longev. 2017;2017:8370593.","journal-title":"Oxid Med Cell Longev"},{"key":"268_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.tips.2015.11.010","volume":"37","author":"L Shen","year":"2016","unstructured":"Shen L, Ji H-F. Intestinal microbiota and metabolic diseases: pharmacological implications. Trends Pharm Sci. 2016;37:169\u201371.","journal-title":"Trends Pharm Sci"},{"key":"268_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109641","volume":"36","author":"WL Sun","year":"2021","unstructured":"Sun WL, Li XY, Dou HY, Wang XD, Li JD, Shen L, et al. Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota. Cell Rep. 2021;36:109641.","journal-title":"Cell Rep"},{"key":"268_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105767","volume":"171","author":"S Dong","year":"2021","unstructured":"Dong S, Zhu M, Wang K, Zhao X, Hu L, Jing W, et al. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Pharm Res. 2021;171:105767.","journal-title":"Pharm Res"},{"key":"268_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.758158","volume":"8","author":"X Zhong","year":"2021","unstructured":"Zhong X, Wang T, Xie Y, Wang M, Zhang W, Dai L, et al. Activated protein C ameliorates diabetic cardiomyopathy modulating OTUB1\/YB-1\/MEF2B axis. Front Cardiovasc Med. 2021;8:758158.","journal-title":"Front Cardiovasc Med"},{"key":"268_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154712","volume":"117","author":"G Yang","year":"2021","unstructured":"Yang G, Wei J, Liu P, Zhang Q, Tian Y, Hou G, et al. Role of the gut microbiota in type 2 diabetes and related diseases. Metabolism. 2021;117:154712.","journal-title":"Metabolism"},{"key":"268_CR27","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/1541-4337.12563","volume":"19","author":"YT Loo","year":"2020","unstructured":"Loo YT, Howell K, Chan M, Zhang P, Ng K. Modulation of the human gut microbiota by phenolics and phenolic fiber-rich foods. Compr Rev Food Sci Food Saf. 2020;19:1268\u201398.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"268_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-021-00446-0","volume":"13","author":"AL Cunningham","year":"2021","unstructured":"Cunningham AL, Stephens JW, Harris DA. Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut Pathog. 2021;13:50.","journal-title":"Gut Pathog"},{"key":"268_CR29","doi-asserted-by":"crossref","unstructured":"The Integrative Human Microbiome Project. Nature. 2019;569:641-8.","DOI":"10.1038\/s41586-019-1238-8"},{"key":"268_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1463-1326.2011.01483.x","volume":"14","author":"RS Kootte","year":"2012","unstructured":"Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14:112\u201320.","journal-title":"Diabetes Obes Metab"},{"key":"268_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.clnu.2020.05.025","volume":"40","author":"M Vitale","year":"2021","unstructured":"Vitale M, Giacco R, Laiola M, Della Pepa G, Luongo D, Mangione A, et al. Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: can SCFAs play a role? Clin Nutr. 2021;40:428\u201337.","journal-title":"Clin Nutr"},{"key":"268_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02213-2","volume":"18","author":"Y-W Tao","year":"2020","unstructured":"Tao Y-W, Gu Y-L, Mao X-Q, Zhang L, Pei Y-F. Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med. 2020;18:30.","journal-title":"J Transl Med"},{"key":"268_CR33","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li Z-R, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139:1619\u201325.","journal-title":"J Nutr"},{"key":"268_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200.","journal-title":"Gut Microbes"},{"key":"268_CR35","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325\u201340.","journal-title":"J Lipid Res"},{"key":"268_CR36","doi-asserted-by":"publisher","first-page":"e0180190","DOI":"10.1371\/journal.pone.0180190","volume":"12","author":"WN D\u2019Souza","year":"2017","unstructured":"D\u2019Souza WN, Douangpanya J, Mu S, Jaeckel P, Zhang M, Maxwell JR, et al. Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses. PLoS ONE. 2017;12:e0180190.","journal-title":"PLoS ONE"},{"key":"268_CR37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jnutbio.2013.02.009","volume":"24","author":"B Ruiz-N\u00fa\u00f1ez","year":"2013","unstructured":"Ruiz-N\u00fa\u00f1ez B, Pruimboom L, Dijck-Brouwer DAJ, Muskiet FAJ. Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context. J Nutr Biochem. 2013;24:1183\u2013201.","journal-title":"J Nutr Biochem"},{"key":"268_CR38","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"PD Cani","year":"2008","unstructured":"Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470\u201381.","journal-title":"Diabetes"},{"key":"268_CR39","doi-asserted-by":"crossref","unstructured":"Pasini E, Corsetti G, Assanelli D, Testa C, Romano C, Dioguardi FS, et al. Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes. Minerva Med. 2019;110:3\u201311.","DOI":"10.23736\/S0026-4806.18.05589-1"},{"key":"268_CR40","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/cbin.10323","volume":"38","author":"X-H Min","year":"2014","unstructured":"Min X-H, Yu T, Qing Q, Yuan Y-H, Zhong W, Chen G-C, et al. Abnormal differentiation of intestinal epithelium and intestinal barrier dysfunction in diabetic mice associated with depressed Notch\/NICD transduction in Notch\/Hes1 signal pathway. Cell Biol Int. 2014;38:1194\u2013204.","journal-title":"Cell Biol Int"},{"key":"268_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11892-018-1104-3","volume":"18","author":"X Chen","year":"2018","unstructured":"Chen X, Devaraj S. Gut microbiome in obesity, metabolic syndrome, and diabetes. Curr Diab Rep. 2018;18:129.","journal-title":"Curr Diab Rep"},{"key":"268_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229\u201341.","journal-title":"Cell"},{"key":"268_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1172\/JCI6709","volume":"104","author":"S Frantz","year":"1999","unstructured":"Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Investig. 1999;104:271\u201380.","journal-title":"J Clin Investig"},{"key":"268_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-133","volume":"8","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Peng T, Zhu H, Zheng X, Zhang X, Jiang N, et al. Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4. J Transl Med. 2010;8:133.","journal-title":"J Transl Med"},{"key":"268_CR45","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.bbadis.2015.07.015","volume":"1852","author":"A Tao","year":"2015","unstructured":"Tao A, Song J, Lan T, Xu X, Kvietys P, Kao R, et al. Cardiomyocyte\u2013fibroblast interaction contributes to diabetic cardiomyopathy in mice: role of HMGB1\/TLR4\/IL-33 axis. Biochim Biophys Acta. 2015;1852:2075\u201385.","journal-title":"Biochim Biophys Acta"},{"key":"268_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13997","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Qian Y, Fang Q, Zhong P, Li W, Wang L, et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat Commun. 2017;8:13997.","journal-title":"Nat Commun"},{"key":"268_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/dc10-1676","volume":"34","author":"PJ Pussinen","year":"2011","unstructured":"Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care. 2011;34:392\u20137.","journal-title":"Diabetes Care"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00268-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00268-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00268-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T19:02:35Z","timestamp":1710529355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00268-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1038\/s41387-024-00268-4","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"16 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures on mice were approved by the Committee on the Ethics of Animal Experiments of Shantou University Medical College (Permit No. SUMC2021-250).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"10"}}